| First Author | Ojima K | Year | 2007 |
| Journal | J Biol Chem | Volume | 282 |
| Issue | 19 | Pages | 14493-504 |
| PubMed ID | 17371879 | Mgi Jnum | J:122571 |
| Mgi Id | MGI:3714690 | Doi | 10.1074/jbc.M610806200 |
| Citation | Ojima K, et al. (2007) Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain. J Biol Chem 282(19):14493-504 |
| abstractText | p94/calpain 3 is a Ca(2+)-binding intracellular protease predominantly expressed in skeletal muscles. p94 binds to the N2A and M-line regions of connectin/titin and localizes in the Z-bands. Genetic evidence showing that compromised p94 proteolytic activity leads to muscular dystrophy (limb-girdle muscular dystrophy type 2A) indicates the importance of p94 function in myofibrils. Here we show that a series of p94 splice variants is expressed immediately after muscle differentiation and differentially change localization during myofibrillogenesis. We found that the endogenous N-terminal (but not C-terminal) domain of p94 was not only localized in the Z-bands but also directly bound to sarcomeric alpha-actinin. These data suggest the incorporation of proteolytic N-terminal fragments of p94 into the Z-bands. In myofibrils localization of exogenously expressed p94 shifted from the M-line to N2A as the sarcomere lengthens beyond approximately 2.6 and 2.8 microm for wild-type and proteaseinactive p94, respectively. These data demonstrate for the first time that p94 proteolytic activity is involved in responses to muscle conditions, which may explain why p94 inactivation causes limb-girdle muscular dystrophy. |
